Anti-metastasais therapy: Tumor suppressor p63 suppresses prostate cancer metastasis through down regulation of MMP2, 29/August/2014, 11.15 am

Anti-metastasais therapy: Tumor suppressor p63 suppresses prostate cancer metastasis through down regulation of MMP2, 29/August/2014, 11.15 am

Anti-metastasais therapy: Tumor suppressor p63 suppresses prostate cancer metastasis through down regulation of MMP2, 29/August/2014, 11.15 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Anti-metastasais therapy: Tumor suppressor p63 suppresses prostate cancer metastasis through down regulation of MMP2, 29/August/2014, 11.15 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org.

Significance: This study suggests that p63, by increasing the expression of its target gene, it may decrease the expression of matrix metalloproteinase-2 (MMP2).  Furthermore, this study suggests that pharmacological formulations encompassing “p63 activator” may inhibit prostate cancer metastasis.